Keittisak Suwan

Title: Keittisak Suwan: Innovator in Cancer Treatment

Introduction

Keittisak Suwan is a notable inventor based in London, GB. He has made significant contributions to the field of cancer treatment through his innovative work. His research focuses on the development of phagemid vectors and associated particles aimed at improving cancer management.

Latest Patents

Keittisak Suwan holds a patent related to cancer treatment. The invention provides phagemid vectors and associated phagemid particles for cancer treatment. It specifically addresses the use of novel phagemid particles and expression systems for the treatment, prevention, amelioration, or management of cancer. The invention emphasizes the delivery of transgenes encoding cytokines, enhancing the effectiveness of cancer therapies. Additionally, it explores the combination of phagemid particles with adoptively transferred T cells for improved treatment outcomes.

Career Highlights

Keittisak Suwan is associated with Imperial College Innovations Limited, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential to revolutionize therapeutic approaches in oncology.

Collaborations

Some of his notable coworkers include Amin Hajitou and Mariam Albahrani, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Keittisak Suwan's innovative work in cancer treatment exemplifies the potential of phagemid technology in enhancing therapeutic strategies. His contributions are paving the way for new advancements in the fight against cancer.